| Multimodal approaches to the treatment of hepatocellular carcinoma G Cabibbo, F Latteri, M Antonucci, A Craxì Nature Reviews Gastroenterology & Hepatology 6 (3), 159-169, 2009 | 116 | 2009 |
| Natural history of untreatable hepatocellular carcinoma: a retrospective cohort study G Cabibbo, M Maida, C Genco, P Parisi, M Peralta, M Antonucci, ... World journal of hepatology 4 (9), 256, 2012 | 100 | 2012 |
| Causes of and prevention strategies for hepatocellular carcinoma G Cabibbo, M Maida, C Genco, M Antonucci, C Cammà Seminars in oncology 39 (4), 374-383, 2012 | 63 | 2012 |
| AGILE 3+ score for the diagnosis of advanced fibrosis and for predicting liver-related events in NAFLD G Pennisi, M Enea, A Pandolfo, C Celsa, M Antonucci, C Ciccioli, ... Clinical Gastroenterology and Hepatology 21 (5), 1293-1302. e5, 2023 | 33 | 2023 |
| Transarterial chemoembolization and sorafenib in hepatocellular carcinoma G Cabibbo, S Tremosini, G Galati, G Mazza, G Gadaleta-Caldarola, ... Expert review of anticancer therapy 14 (7), 831-845, 2014 | 23 | 2014 |
| Curative therapies for hepatocellular carcinoma: an update and perspectives R Sacco, M Antonucci, G Bresci, A Corti, L Giacomelli, V Mismas, ... Expert review of anticancer therapy 16 (2), 169-175, 2016 | 12 | 2016 |
| Transarterial chemoembolization and sorafenib in patients with intermediate-stage hepatocellular carcinoma: time to enter routine clinical practice? R Sacco, M Antonucci, I Bargellini, S Marceglia, V Mismas, G Cabibbo Future Oncology 11 (17), 2371-2373, 2015 | 12 | 2015 |
| Minor hepatic resection for hepatocellular carcinoma in cirrhotic patients: Kelly clamp crushing resection versus heat coagulative necrosis with bipolar radiofrequency device L Sandonato, M Soresi, C Cipolla, TV Bartolotta, L Giannitrapani, ... The American Surgeon 77 (11), 1490-1495, 2011 | 8 | 2011 |
| Update on new approaches in the management of hepatocellular carcinoma G Cabibbo, M Antonucci, C Genco Hepatic Medicine: Evidence and Research, 163-173, 2010 | 8 | 2010 |
| Balancing efficacy and tolerability of first-line systemic therapies for advanced hepatocellular carcinoma: a network metanalysis C Celsa, G Cabibbo, DJ Pinato, G Maria, M Enea, M Vaccaro Liver Cancer 10, 000531744, 2023 | 5 | 2023 |
| The evolving scenario in the assessment of radiological response for hepatocellular carcinoma in the era of immunotherapy: strengths and weaknesses of surrogate endpoints P Giuffrida, C Celsa, M Antonucci, M Peri, MV Grassini, G Rancatore, ... Biomedicines 10 (11), 2827, 2022 | 4 | 2022 |
| Ultrasound-guided ablation for hepatocellular carcinoma: time for a reappraisal? G Cabibbo, M Antonucci, R Sacco, E Sciarrino Expert Review of Anticancer Therapy 15 (2), 147-150, 2015 | 3 | 2015 |
| Liver investigation: Testing marker utility in steatohepatitis (LITMUS): Assessment & validation of imaging modality performance across the NAFLD spectrum in a prospectively … M Pavlides, FE Mózes, S Akhtar, K Wonders, J Cobbold, EM Tunnicliffe, ... Contemporary clinical trials 134, 107352, 2023 | 2 | 2023 |
| LI-RADS ancillary features favoring benignity: is there a role in LR-5 observations? R Cannella, F Vernuccio, M Antonucci, DS Gagliano, F Matteini, M Midiri, ... European Radiology, 1-9, 2022 | 1 | 2022 |
| T. 07.7: CHARACTERISTICS AND MANAGEMENT OF HEPATOCELLULAR CARCINOMA (HCC) IN SICILY: FIRST RESULTS OF THE HCC SICILY MULTIDISCIPLINARY NETWORK C Celsa, G Cabibbo, R Ciccia, G Di Maria, D Pagano, R Miraglia, ... Digestive and Liver Disease 56, S258, 2024 | | 2024 |
| Characteristics and management of hepatocellular carcinoma (HCC) in Sicily: first results of the HCC Sicily Multidisciplinary Network C Celsa, G Cabibbo, R Ciccia, G Di Maria, D Pagano, R Miraglia, ... Digestive and Liver Disease 56, S83-S84, 2024 | | 2024 |
| Network meta-analysis of first-line systemic therapies for advanced hepatocellular carcinoma: Who is the winner? C Celsa, G Cabibbo, GEM Rizzo, P Giuffrida, M Enea, G Di Maria, ... Digestive and Liver Disease 55, S3, 2023 | | 2023 |
| Diagnostic performance of AGILE 3+ score for identification of advanced fibrosis and prediction of liver-related events in patients with non-alcoholic fatty liver disease G Pennisi, C Celsa, M Enea, A Pandolfo, M Antonucci, C Ciccioli, ... Journal of Hepatology 77, S448, 2022 | | 2022 |
| The Evolving Scenario in the Assessment of Radiological Response for Hepatocellular Carcinoma in the Era of Immunotherapy: Strengths and Weaknesses of Surrogate Endpoints … P Giuffrida, C Celsa, M Antonucci, M Peri, MV Grassini, G Rancatore, ... s Note: MDPI stays neu-tral with regard to jurisdictional claims in …, 2022 | | 2022 |
| Role of Ultrasonography in the Management of Breast Cancer: a Review of the Literature M Antonucci Terapia Evidence Based 5 (4), 2012 | | 2012 |
